Hypercalcemic and hypophosphatemic effects of dibutyryl cyclic AMP in rats after parathyroidectomy.
D000227:Adenine Nucleotides / Q000502:physiology; D000818:Animals; D001842:Bone and Bones / Q000201:enzymology; D002116:Calcitonin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000502:physiology; D006934:Hypercalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D010280:Parathyroid Glands / Q000601:surgery; D010281:Parathyroid Hormone / Q000502:physiology; D010710:Phosphates / Q000097:blood*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D000227:Adenine Nucleotides; D007093:Imidazoles; D010281:Parathyroid Hormone; D010710:Phosphates; D002116:Calcitonin; D013806:Theophylline; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D007545:Isoproterenol; D002118:Calcium